Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides

References

1. Britt W. J., Vugler L., Stephens E. B. 1988; Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). Journal of Virology 62:3309–3318
   [Google Scholar]
2. Cranage M. P., Smith G. L., Bell S. E., Hart H., Brown C., Bankier A. T., Tomlinson P., Barrell B. G., Minson T. C. 1988; Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62:1416–1422
   [Google Scholar]
3. Dillner J., Sternas L., Kallin B., Klein G., Lerner R. A. 1984; Antibodies against a synthetic peptide identify the Epstein–Barr virus determined nuclear antigen. Proceedings of the National Academy of Sciences, U.S.A 81:4652–4656
   [Google Scholar]
4. Durack D. T. 1984; Opportunistic infections and Kaposi’s sarcoma in homosexual men. New England Journal of Medicine 305:1465–1467
   [Google Scholar]
5. Geysen H. M., Tainer J. A., Rodda S. J., Mason T. J., Alexander H., Getzoff E. D., Lerner R. A. 1987a; Chemistry of antibody binding to a protein. Science 235:1184–1190
   [Google Scholar]
6. Geysen H. M., Rodda S. J., Mason T. J., Tribbick G., Schoofs P. G. 1987b; Strategies for epitope analysis using peptide synthesis. Journal of Immunological Methods 102:259–274
   [Google Scholar]
7. Griffiths P. D. 1989; Diagnosis of cytomegalovirus infection. Journal of Antimicrobial Chemotherapy 23: supplement E11–16
   [Google Scholar]
8. Jahn G., Kouzarides T., Mach M., Scholl B.-C., Plachter B., Traupe B., Preddie E., Satchwell S. C., Fleckenstein B., Barrell B. G. 1987; Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. Journal of Virology 61:1358–1367
   [Google Scholar]
9. Krchňák V., Vágner J. 1990; Color-monitored solid-phase multiple peptide synthesis under low-pressure continuous flow conditions. Peptide Research 3:182–187
   [Google Scholar]
10. Krchňák V., Vágner J., Flegel M., Mach O. 1987; Continuous flow solid-phase peptide synthesis. Tetrahedron Letters 28:4469–4472
    [Google Scholar]
11. Krchňák V., Vágner J., Mach O. 1989; Multiple continuous flow solid-phase peptide synthesis: the synthesis of an HIV antigenic peptide and its omission analogues. International Journal of Peptide and Protein Research 33:209–213
    [Google Scholar]
12. Landini M. P., Re M. C., Mirolo G., Baldassari B., La Placa M. 1985; Human immune response to cytomegalovirus structural polypetides studied by immunoblotting. Journal of Medical Virology 17:303–311
    [Google Scholar]
13. Landini M. P., Rossier E., Schmitz H. 1988; Antibodies to human cytomegalovirus structural polypeptides during primary infection. Journal of Virological Methods 22:309–317
    [Google Scholar]
14. Landini M. P., Guan M. X., Jahn G., Lindenmaier W., Mach M., Ripalti A., Necker A., Lazzarotto T., Plachter B. 1990; Large-scale screening of human sera with cytomegalovirus recombinant antigens. Journal of Clinical Microbiology 28:1375–1379
    [Google Scholar]
15. Mach M., Stamminger T., Jahn G. 1989; Human cytomegalovirus: recent aspects from molecular biology. Journal of General Virology 70:3117–3146
    [Google Scholar]
16. Middeldorp J. M., Meloen R. H. 1988; Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. Journal of Virological Methods 21:147–159
    [Google Scholar]
17. Myers J. D., Fluornoy N., Thomas E. D. 1982; Nonbacterial pneumonia after allogenic marrow transplantation: a review of ten years’ experience. Reviews of Infectious Diseases 4:1119–1132
    [Google Scholar]
18. Narvanen A., Korkolainen M., Kontio S., Suni J., Turtiainen S., Partanen S., Vaheri A., Huhtala M.-L. 1988; Highly immunoreactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods. AIDS 2:119–123
    [Google Scholar]
19. Ruger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Schmitz H., Kampa D., Doerr H. W., Luthard T., Hillemans H. G. 1977; IgM antibodies to cytomegalovirus during pregnancy. Archives of Virology 53:177–184
    [Google Scholar]
20. Schmitz H., Mohr H., Majoubi M. 1986; Differentiation between primary and recurrent cytomegalovirus infections. Archives of Virology 90:41–51
    [Google Scholar]
21. Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. 1982; Congenital cytomegalovirus infection. The relative importance of primary and recurrent maternal infection. New England Journal of Medicine 306:945–949
    [Google Scholar]
22. Van Regenmortel M. H. V., Briand J. P., Muller S., Plaue S. 1988 In Laboratory Techniques in Biochemistry and Molecular Biology: Synthetic Polypeptides as Antigens pp 1–39 Edited by Burdon R. H., Van Knippenberg P. H. Amsterdam: Elsevier;
    [Google Scholar]
23. Vestergaard B. F., Graubale P. C. I., Spangaard H. 1977; Titration of herpes simplex virus antibodies in human sera by the enzyme-linked immunosorbent assay (ELISA). Acta pathologica et microbiologica scandinavica (B) 85:466–468
    [Google Scholar]